“…This lower proportion may be explained by the recruitment of the tested patients in our series: we tested all patterns of CADR, including FDE, DIGAL, SJS/TEN, and erythrodermia, for which PTs are not very sensitive . Moreover, studies concerning PTs for CADRs showed that the value of the test depends on the initial clinical features and the suspected CADR drug . The results of our study, obtained with the same types of drugs and CADRs, were similar.…”